SecBot SecBot
6-K ·Filed Apr 8, 2026

ENLV

Enlivex Ltd.
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago SEC0001213900-26-041277
Notable filing: 6-K
Actionable Insight • Neutral

Traders should monitor whether tokenization leads to increased trading volume or broader investor interest, particularly from crypto-native markets. However, no immediate fundamental change in valuation or cash flow is expected.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
ENLV ▼ -43.41% at T+60d
NEUTRAL call -43.41% · α vs SPY -53.87% · entry $0.9330 → $0.5280
Entry = T+0 close
Apr 8, 2026
via day close
T+1d
+1.82%
call +1.82% · α +1.25%
$0.9500
settled 7mo ago
T+5d
-12.11%
call -12.11% · α -15.63%
$0.8200
settled 7mo ago
T+20d
-12.11%
call -12.11% · α -20.66%
$0.8200
settled 6mo ago
T+60d
-43.41%
call -43.41% · α -53.87%
$0.5280
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Enlivex announced the launch of ENLVon, a tokenized representation of its ordinary shares on Ondo Finance's Global Markets platform, enabling non-U.S. investors to gain economic exposure to ENLV through blockchain infrastructure. This move expands accessibility to digitally native investors but does not involve new capital raising or financial transactions.

Key Facts

  • Ondo Finance launched ENLVon, a tokenized version of Enlivex's ordinary shares, on April 8, 2026.
  • ENLVon allows non-U.S. retail and institutional investors to access ENLV shares via digital wallets without traditional brokerage accounts.
  • The tokenization enables fractional ownership, near-instant settlement, and integration into DeFi applications such as lending and yield strategies.
  • This is a structural innovation in investor access, not a capital-raising event or change in underlying equity structure.

Financial Impact

No direct financial impact; no proceeds or dilution involved.

liquidityinvestor accessmarket visibility

Risk Factors

  • Regulatory uncertainty around tokenized securities could limit adoption.
  • Limited real-world demand for tokenized equities may result in low trading activity for ENLVon.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-041277
Document: ea028537601ex99-1.htm0001213900-26-041277
Document: 0001213900-26-041277-index-headers.html0001213900-26-041277
Document: 0001213900-26-041277-index.html0001213900-26-041277
Document: 0001213900-26-041277.txt0001213900-26-041277
22 reports for ENLV
Performance horizon
64% Hit rate @ T+5 7 of 11 directional calls Went positive at some point 9 of 11 best @ T+60▲ +90.97%Jul 28, 2026
Filters
Rows
Reports for ENLV — sortable, filterable
TypeNow
Oct 27, 2026
today
6-K
BEARISH ★ 6/10
$0.1734awaiting T+5—$2.70 (−1457.09%)
Oct 22, 2026
5d ago
6-K
NEUTRAL ★ 3/10
$0.1734awaiting T+5—$2.70 (+1457.09%)
Oct 22, 2026
5d ago
Press Release
NEUTRAL ★ 3/10
$0.1734awaiting T+5—$2.70 (+1457.09%)
Oct 19, 2026
8d ago
6-K
BEARISH ★ 6/10
$0.2070 $0.1704▲ +17.68%▲ +17.54%$2.70 (−1204.35%)
Oct 19, 2026
8d ago
Press Release
BEARISH ★ 6/10
$0.2070 $0.1704▲ +17.68%▲ +17.54%$2.70 (−1204.35%)
Sep 25, 2026
4w ago
6-K
NEUTRAL ★ 5/10
$0.5140 $0.3620▼ −29.57%▼ −30.78%$2.70 (+425.29%)
Sep 22, 2026
5w ago
6-K
BULLISH ★ 6/10
$0.6464 $0.4801▼ −25.73%▼ −24.54%$2.70 (+317.70%)
Aug 14, 2026
10w ago
EFFECT
NEUTRAL ★ 4/10
$1.58 $1.47▼ −6.96%▼ −5.59%$2.70 (+70.89%)
Jul 30, 2026
12w ago
6-K
BULLISH ★ 5/10
$1.95 $1.98▲ +1.54%▼ −2.08%$2.70 (+38.46%)
Jul 29, 2026
12w ago
6-K
NEUTRAL ★ 3/10
$2.25 $2.18▼ −3.11%▼ −8.64%$2.70 (+20.00%)
Showing 10 of 22

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 8, 2026